Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 584

1.

Atrial fibrillation and coronary stenting: is the AUGUSTUS trial the end of triple therapy?

Zwart B, Ten Berg JM.

Future Cardiol. 2019 Aug 6. doi: 10.2217/fca-2019-0027. [Epub ahead of print] No abstract available.

PMID:
31385524
2.

First Use of Futuristic Image Fusion Technology During Transcatheter Aortic Valve Replacement.

Brouwer J, Ten Berg JM, Rensing BJWM, Swaans MJ.

JACC Cardiovasc Interv. 2019 Jul 25. pii: S1936-8798(19)31437-2. doi: 10.1016/j.jcin.2019.06.047. [Epub ahead of print] No abstract available.

PMID:
31377270
3.

Nephrogenic diabetes insipidus in a 15-year-old Hispanic female with a novel AQP2 mutation.

Long BC, Weber ZJ, Oberlin JM, Sutter DE, Berg JM.

J Pediatr Endocrinol Metab. 2019 Jul 26. pii: /j/jpem.ahead-of-print/jpem-2019-0099/jpem-2019-0099.xml. doi: 10.1515/jpem-2019-0099. [Epub ahead of print]

PMID:
31348762
4.

Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5).

Verheugt FWA, Ten Berg JM, Storey RF, Cuisset T, Granger CB.

J Am Coll Cardiol. 2019 Aug 6;74(5):699-711. doi: 10.1016/j.jacc.2019.02.080. Epub 2019 Jul 2. Review.

PMID:
31277840
5.

Measuring high on-treatment platelet reactivity in clinical practice; should we use a panel of platelet function tests?

Zwart B, Godschalk TC, Zheng K, Denteneer J, Kelder JC, Ten Berg JM.

Blood Coagul Fibrinolysis. 2019 Sep;30(6):263-269. doi: 10.1097/MBC.0000000000000831.

PMID:
31259779
6.

Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment.

Bergmeijer TO, van Oevelen M, Janssen PWA, Godschalk TC, Lichtveld RA, Kelder JC, Voskuil M, Mosterd A, Montalescot G, Ten Berg JM.

TH Open. 2018 Oct 11;2(4):e357-e368. doi: 10.1055/s-0038-1673389. eCollection 2018 Oct.

7.

Consider the wrist: a retrospective study on pediatric connective tissue disease with MRI.

Nusman CM, van den Berg JM, Nassar-Sheikh Rashid A, Ntailiani K, Karantanas A, Kuijpers TW, Maas M, Schonenberg-Meinema D.

Rheumatol Int. 2019 Jun 20. doi: 10.1007/s00296-019-04353-1. [Epub ahead of print]

PMID:
31222439
8.

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.

Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, Ten Berg JM, Sarafoff N, Gibson CM, Alexander JH.

JAMA Cardiol. 2019 Jun 19. doi: 10.1001/jamacardio.2019.1880. [Epub ahead of print]

PMID:
31215979
9.

Tailored P2Y12 inhibitor treatment in patients undergoing non-urgent PCI-the POPular Risk Score study.

Janssen PWA, Bergmeijer TO, Vos GA, Kelder JC, Qaderdan K, Godschalk TC, Breet NJ, Deneer VHM, Hackeng CM, Ten Berg JM.

Eur J Clin Pharmacol. 2019 Sep;75(9):1201-1210. doi: 10.1007/s00228-019-02696-z. Epub 2019 Jun 14.

PMID:
31197411
10.

Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial.

Power D, Schäfer U, Guedeney P, Claessen BE, Sartori S, Sorrentino S, Lefèvre T, Kupatt C, Tchetche D, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Jeger R, Sardella G, Hink U, Husser O, Grube E, Lechthaler I, Wijngaard P, Anthopoulos P, Deliargyris EN, Bernstein D, Hengstenberg C, Mehran R, Dangas GD.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1374-1381. doi: 10.1002/ccd.28295. Epub 2019 May 22.

PMID:
31116908
11.

Veno arterial-extra corporal membrane oxygenation for the treatment of cardiac failure in patients with infective endocarditis.

van den Brink FS, van Tooren R, Sonker U, Klein P, Waanders F, Zivelonghi C, Eefting FD, Scholten E, Ten Berg JM.

Perfusion. 2019 Apr 26:267659119842807. doi: 10.1177/0267659119842807. [Epub ahead of print]

PMID:
31027458
12.

Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands.

Ten Haaf ME, Bax M, Ten Berg JM, Brouwer J, Van't Hof AW, van der Schaaf RJ, Stella PR, Tjon Joe Gin RM, Tonino PA, de Vries AG, Zijlstra F, Boersma E, Appelman Y.

Neth Heart J. 2019 May;27(5):263-271. doi: 10.1007/s12471-019-1271-0.

13.

Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial.

Lip GYH, Mauri L, Montalescot G, Ozkor M, Vardas P, Steg PG, Bhatt DL, Hohnloser SH, Miede C, Nordaby M, Brueckmann M, Kreuzer J, Kimura T, Oldgren J, Ten Berg JM, Cannon CP.

Am Heart J. 2019 Jun;212:13-22. doi: 10.1016/j.ahj.2019.02.006. Epub 2019 Mar 1.

PMID:
30928824
14.

A "minimalistic hybrid algorithm" in coronary chronic total occlusion revascularization: Procedural and clinical outcomes.

Zivelonghi C, van Kuijk JP, Poletti E, Suttorp MJ, Eefting FD, Rensing BJ, Ten Berg JM, Colombo A, Azzalini L, Agostoni P.

Catheter Cardiovasc Interv. 2019 Mar 14. doi: 10.1002/ccd.28213. [Epub ahead of print]

PMID:
30919577
15.

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.

Patel RS, Schmidt AF, Tragante V, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Dubé MP, Allayee H, Almgren P, Alver M, Baranova EV, Behlouli H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dufresne L, Eriksson N, Foco L, Gijsberts CM, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Fitzpatrick N, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Bogaty P, de Borst GJ, Brenner H, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Johnson JA, de Jong PA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Pepinski W, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Scholz M, Siegbahn A, Sinisalo J, Smith JG, Spertus JA, Stewart AFR, Szczeklik W, Szpakowicz A, Ten Berg JM, Thanassoulis G, Thiery J, van der Graaf Y, Visseren FLJ, Waltenberger J; CARDIoGRAMPlusC4D Consortium, Van der Harst P, Tardif JC, Sattar N, Lang CC, Pare G, Brophy JM, Anderson JL, März W, Wallentin L, Cameron VA, Horne BD, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002471. doi: 10.1161/CIRCGEN.119.002471. Epub 2019 Mar 21.

PMID:
30897348
16.

Subsequent Event Risk in Individuals With Established Coronary Heart Disease.

Patel RS, Tragante V, Schmidt AF, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Allayee H, Almgren P, Alver M, Baranova EV, Behloui H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dubé MP, Dufresne L, Eriksson N, Foco L, Scholz M, Gijsberts CM, Glinge C, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kotti S, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, Van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Al Ali L, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Engstrøm T, Fitzpatrick N, Fox K, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton-Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Boersma EH, Bogaty P, Bots ML, Brenner H, Brugts JJ, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, Danchin N, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Grobbee DE, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Jabbari R, Johnson JA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Niemcunowicz-Janica A, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Siegbahn A, Simon T, Sinisalo J, Smith JG, Spertus JA, Stender S, Stewart AFR, Szczeklik W, Szpakowicz A, Tardif JC, Ten Berg JM, Tfelt-Hansen J, Thanassoulis G, Thiery J, Torp-Pedersen C, van der Graaf Y, Visseren FLJ, Waltenberger J, Weeke PE, Van der Harst P, Lang CC, Sattar N, Cameron VA, Anderson JL, Brophy JM, Pare G, Horne BD, März W, Wallentin L, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002470. doi: 10.1161/CIRCGEN.119.002470. Epub 2019 Mar 21.

PMID:
30896328
17.

Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.

Nijenhuis VJ, Brouwer J, Søndergaard L, Collet JP, Grove EL, Ten Berg JM.

Heart. 2019 May;105(10):742-748. doi: 10.1136/heartjnl-2018-314313. Epub 2019 Mar 13. Review.

PMID:
30867148
18.

Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation.

Wienke J, Bellutti Enders F, Lim J, Mertens JS, van den Hoogen LL, Wijngaarde CA, Yeo JG, Meyer A, Otten HG, Fritsch-Stork RDE, Kamphuis SSM, Hoppenreijs EPAH, Armbrust W, van den Berg JM, Hissink Muller PCE, Tekstra J, Hoogendijk JE, Deakin CT, de Jager W, van Roon JAG, van der Pol WL, Nistala K, Pilkington C, de Visser M, Arkachaisri T, Radstake TRDJ, van der Kooi AJ, Nierkens S, Wedderburn LR, van Royen-Kerkhof A, van Wijk F.

Arthritis Rheumatol. 2019 Aug;71(8):1377-1390. doi: 10.1002/art.40881. Epub 2019 Mar 12.

PMID:
30861625
19.

Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?

Ten Berg JM, Claassens DMF.

Neth Heart J. 2019 Apr;27(4):169-170. doi: 10.1007/s12471-019-1262-1. No abstract available.

20.

Usefulness of Clopidogrel Loading in Patients Who Underwent Transcatheter Aortic Valve Implantation (from the BRAVO-3 Randomized Trial).

Nijenhuis VJ, Ten Berg JM, Hengstenberg C, Lefèvre T, Windecker S, Hildick-Smith D, Kupatt C, Van Belle E, Tron C, Hink HU, Colombo A, Claessen B, Sartori S, Chandrasekhar J, Mehran R, Anthopoulos P, Deliargyris EN, Dangas G.

Am J Cardiol. 2019 May 1;123(9):1494-1500. doi: 10.1016/j.amjcard.2019.01.049. Epub 2019 Feb 10.

PMID:
30826050
21.

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.

Oldgren J, Steg PG, Hohnloser SH, Lip GYH, Kimura T, Nordaby M, Brueckmann M, Kleine E, Ten Berg JM, Bhatt DL, Cannon CP.

Eur Heart J. 2019 May 14;40(19):1553-1562. doi: 10.1093/eurheartj/ehz059.

22.

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.

Kessler T, Wolf B, Eriksson N, Kofink D, Mahmoodi BK, Rai H, Tragante V, Åkerblom A, Becker RC, Bernlochner I, Bopp R, James S, Katus HA, Mayer K, Munz M, Nordio F, O'Donoghue ML, Sager HB, Sibbing D, Solakov L, Storey RF, Wobst J, Asselbergs FW, Byrne RA, Erdmann J, Koenig W, Laugwitz KL, Ten Berg JM, Wallentin L, Kastrati A, Schunkert H.

Cardiovasc Res. 2019 Aug 1;115(10):1512-1518. doi: 10.1093/cvr/cvz015.

PMID:
30768153
23.

Prolonged time between intravenous contrast administration and image acquisition results in increased synovial thickness at magnetic resonance imaging in patients with juvenile idiopathic arthritis.

Barendregt AM, van Gulik EC, Groot PFC, Dolman KM, van den Berg JM, Nassar-Sheikh Rashid A, Schonenberg-Meinema D, Lavini C, Rosendahl K, Hemke R, Kuijpers TW, Maas M, Nusman CM.

Pediatr Radiol. 2019 May;49(5):638-645. doi: 10.1007/s00247-018-04332-x. Epub 2019 Feb 1.

PMID:
30707259
24.

Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.

Fabris E, Ottervanger JP, Hermanides RS, Ten Berg JM, Sinagra G, Koopmans PC, Giannitsis E, Hamm C, van 't Hof AWJ.

Catheter Cardiovasc Interv. 2019 Apr 1;93(5):E293-E297. doi: 10.1002/ccd.28043. Epub 2018 Dec 26.

PMID:
30585388
25.

Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?

Hissink Muller PCE, Yildiz B, Allaart CF, Brinkman DMC, van Rossum M, van Suijlekom-Smit LWA, van den Berg JM, Ten Cate R, de Vries MC.

BMC Med Ethics. 2018 Dec 20;19(1):96. doi: 10.1186/s12910-018-0336-8.

26.

Editorial retraction.

Berg JM, Smith OM.

Sci Transl Med. 2018 Dec 12;10(471). pii: eaaw2634. doi: 10.1126/scitranslmed.aaw2634. No abstract available.

27.

Correction to: Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents.

Barendregt AM, van Gulik EC, Lavini C, Nusman CM, van den Berg JM, Schonenberg-Meinema D, Dolman KM, Kuijpers TW, Hemke R, Maas M.

Eur Radiol. 2019 Jun;29(6):3319-3320. doi: 10.1007/s00330-018-5881-5.

PMID:
30506215
28.

Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization.

Zivelonghi C, Suttorp MJ, Teeuwen K, van Kuijk JP, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, van den Brink FS, Benfari G, Tijssen JGP, Ribichini F, Henriques JPS, Agostoni P.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2343-2345. doi: 10.1016/j.jcin.2018.07.038. No abstract available.

PMID:
30466836
29.

Insight on patient specific computer modeling of transcatheter aortic valve implantation in patients with bicuspid aortic valve disease.

Brouwer J, Gheorghe L, Nijenhuis VJ, Ten Berg JM, Rensing BJWM, van der Heyden JAS, Swaans MJ.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1097-1105. doi: 10.1002/ccd.27990. Epub 2018 Nov 20.

PMID:
30461187
30.

Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient-years of follow up.

Snijder RJR, Renes LE, Suttorp MJ, Ten Berg JM, Post MC.

Catheter Cardiovasc Interv. 2019 May 1;93(6):1080-1084. doi: 10.1002/ccd.27984. Epub 2018 Nov 20.

PMID:
30461175
31.

Implementing a minimally invasive approach (combining radial approach, small guiding catheters and minimization of double access) for coronary chronic total occlusion intervention according to the hybrid algorithm: The Minimalistic Hybrid Algorithm.

Zivelonghi C, van Kuijk JP, Suttorp MJ, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, Agostoni P.

Int J Cardiol. 2019 May 15;283:84-87. doi: 10.1016/j.ijcard.2018.11.021. Epub 2018 Nov 9.

PMID:
30449693
32.

Using extra systoles and the micro-fluid challenge to predict fluid responsiveness during cardiac surgery.

Vistisen ST, Berg JM, Boekel MF, Modestini M, Bergman R, Jainandunsing JS, Mariani MA, Scheeren TWL.

J Clin Monit Comput. 2018 Nov 9. doi: 10.1007/s10877-018-0218-0. [Epub ahead of print]

PMID:
30414054
33.

Perioperative point of care platelet function testing and postoperative blood loss in high-risk cardiac surgery patients.

Vlot EA, Willemsen LM, Van Dongen EPA, Janssen PW, Hackeng CM, Kloppenburg GTL, Kelder JC, Ten Berg JM, Noordzij PG.

Platelets. 2018 Nov 9:1-7. doi: 10.1080/09537104.2018.1542123. [Epub ahead of print]

PMID:
30411659
34.
35.

Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial.

Hissink Muller P, Brinkman DMC, Schonenberg-Meinema D, van den Bosch WB, Koopman-Keemink Y, Brederije ICJ, Bekkering PW, Kuijpers TW, Van Rossum M, van Suijlekom-Smit LW, van den Berg JM, Boehringer S, Allaart CF, Ten Cate R.

Ann Rheum Dis. 2019 Jan;78(1):51-59. doi: 10.1136/annrheumdis-2018-213902. Epub 2018 Oct 11.

PMID:
30309970
36.

Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.

Fabris E, Van't Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Kerneis M, Diallo A, Vicaut E, Montalescot G; ATLANTIC investigators.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):E369-E377. doi: 10.1002/ccd.27921. Epub 2018 Oct 9.

PMID:
30302940
37.

Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial.

Zivelonghi C, van Andel M, Venturi G, Amoroso G, Teeuwen K, Tijssen JGP, Tavella D, Ribichini F, Ten Berg JM, Resning BJ, Henriques JPS, Suttorp MJ, Agostoni P, Van der Schaaf RJ.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):E81-E89. doi: 10.1002/ccd.27795. Epub 2018 Oct 2.

PMID:
30280464
38.

Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocol.

Schoemaker CG, Armbrust W, Swart JF, Vastert SJ, van Loosdregt J, Verwoerd A, Whiting C, Cowan K, Olsder W, Versluis E, van Vliet R, Fernhout MJ, Bookelman SL, Cappon J, van den Berg JM, Schatorjé E, Muller PCEH, Kamphuis S, de Boer J, Lelieveld OTHM, van der Net J, Jongsma KR, van Rensen A, Dedding C, Wulffraat NM.

Pediatr Rheumatol Online J. 2018 Sep 15;16(1):57. doi: 10.1186/s12969-018-0276-3. Review.

39.

Anticoagulant plus antiplatelet therapy for atrial fibrillation : Cost-utility of combination therapy with non-vitamin K oral anticoagulants vs. warfarin.

Bode K, Hindricks G, Ten Berg JM, Whittaker P.

Herz. 2018 Sep 12. doi: 10.1007/s00059-018-4747-6. [Epub ahead of print]

PMID:
30209519
40.

Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).

Joner M, Koppara T, Byrne RA, Castellanos MI, Lewerich J, Novotny J, Guagliumi G, Xhepa E, Adriaenssens T, Godschalk TC, Malik N, Alfonso F, Tada T, Neumann FJ, Desmet W, Ten Berg JM, Gershlick AH, Feldman LJ, Massberg S, Kastrati A; Prevention of PRESTIGE Investigators.

JACC Cardiovasc Interv. 2018 Jul 23;11(14):1340-1350. doi: 10.1016/j.jcin.2018.02.029.

41.

Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands.

Bennaghmouch N, de Veer AJWM, Mahmoodi BK, Jofre-Bonet M, Lip GYH, Bode K, Ten Berg JM.

Eur Heart J Qual Care Clin Outcomes. 2019 Apr 1;5(2):127-135. doi: 10.1093/ehjqcco/qcy030. Review.

PMID:
30016398
42.

2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group.

Arslan F, Bongartz L, Ten Berg JM, Jukema JW, Appelman Y, Liem AH, de Winter RJ, van 't Hof AWJ, Damman P.

Neth Heart J. 2018 Sep;26(9):417-421. doi: 10.1007/s12471-018-1134-0.

43.

Medical Records Flag for Suicide Risk: Predictors and Subsequent Use of Care Among Veterans With Substance Use Disorders.

Berg JM, Malte CA, Reger MA, Hawkins EJ.

Psychiatr Serv. 2018 Sep 1;69(9):993-1000. doi: 10.1176/appi.ps.201700545. Epub 2018 Jun 8.

PMID:
29879873
44.

Strengths and Weaknesses of Two Empathy Measures: A Comparison of the Measurement Precision, Construct Validity, and Incremental Validity of Two Multidimensional Indices.

Murphy BA, Costello TH, Watts AL, Cheong YF, Berg JM, Lilienfeld SO.

Assessment. 2018 May 1:1073191118777636. doi: 10.1177/1073191118777636. [Epub ahead of print]

PMID:
29847994
45.

Juvenile idiopathic arthritis - the role of imaging from a rheumatologist's perspective.

Malattia C, Tzaribachev N, van den Berg JM, Magni-Manzoni S.

Pediatr Radiol. 2018 Jun;48(6):785-791. doi: 10.1007/s00247-017-4014-7. Epub 2018 May 8. Review.

PMID:
29766250
46.

A practical guide on how to handle patients with bleeding events while on oral antithrombotic treatment.

Gimbel ME, Minderhoud SCS, Ten Berg JM.

Neth Heart J. 2018 Jun;26(6):341-351. doi: 10.1007/s12471-018-1117-1. Review.

47.

Optimal treatment of patients with NSTE-ACS in the Dutch health care system.

van Kuijk JP, Ten Berg JM.

Neth Heart J. 2018 Jun;26(6):289-295. doi: 10.1007/s12471-018-1114-4. Review.

48.

Feasibility and implementation of CYP2C19 genotyping in patients using antiplatelet therapy.

Bergmeijer TO, Vos GJ, Claassens DM, Janssen PW, Harms R, der Heide RV, Asselbergs FW, Ten Berg JM, Deneer VH.

Pharmacogenomics. 2018 May;19(7):621-628. doi: 10.2217/pgs-2018-0013. Epub 2018 Apr 27.

49.

Normal MRI findings of the knee in patients with clinically active juvenile idiopathic arthritis.

van Gulik EC, Hemke R, Welsink-Karssies MM, Schonenberg-Meinema D, Dolman KM, Barendregt AM, Nusman CM, Maas M, Kuijpers TW, van den Berg JM.

Eur J Radiol. 2018 May;102:36-40. doi: 10.1016/j.ejrad.2018.02.027. Epub 2018 Mar 6.

PMID:
29685542
50.

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.

Golwala HB, Cannon CP, Steg PG, Doros G, Qamar A, Ellis SG, Oldgren J, Ten Berg JM, Kimura T, Hohnloser SH, Lip GYH, Bhatt DL.

Eur Heart J. 2018 May 14;39(19):1726-1735a. doi: 10.1093/eurheartj/ehy162.

Supplemental Content

Support Center